20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
The iShares Biotechnology ETF (NASDAQ:IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to around 10%.
On CNBC’s “Halftime Report Final Trades,” Jeffrey Mills of Bryn Mawr Trust recommended going long on biotech stocks.
Check out other stocks making moves in the premarket.
Steven Grasso of Grasso Global said that Meta Platforms Inc’s (NASDAQ:META) stock bounced and “it is still going.”
Courtney Garcia of Payne Capital Management chose Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:TSM). “I like emerging markets here,” she added.
Tim Seymour of Seymour Asset Management said Las Vegas Sands Corp. (NYSE:LVS) is another China play that is worth checking.
Photo via Shutterstock.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!